Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (321-330 of 471) with videos related to

Pageof 48
Sort By:
Annals of Medicine|March 9, 2017
Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognitionEli Muchtar, Angela Dispenzieri, Martha Q Lacy, et al.
Mayo Clinic Proceedings|October 8, 2016
Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and OutcomeEli Muchtar, Daniele Derudas, Michelle Mauermann, et al.
European Journal of Haematology|January 29, 2008
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndromeAngela Dispenzieri, Martha Q Lacy, Suzanne R Hayman, et al.
Bone Marrow Transplantation|May 3, 2020
Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplantAbdullah S Al Saleh, M Hasib Sidiqi, JaeWon Lee, et al.
British Journal of Haematology|July 13, 2017
Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantationEli Muchtar, Angela Dispenzieri, Martha Q Lacy, et al.
American Journal of Hematology|November 25, 2021
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patientsPatrick W Mellors, Taxiarchis Kourelis, Ronald S Go, et al.
American Journal of Hematology|July 8, 2023
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myelomaSaurabh Zanwar, Matthew Ho, Yi Lin, et al.
Blood Cancer Journal|October 3, 2020
Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myelomaMarcella A Tschautscher, Dragan Jevremovic, Francis K Buadi, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|December 19, 2022
The impact of Post-Transplant doxycycline in AL amyloidosis - updated results after Long-Term follow upNadine Abdallah, Angela Dispenzieri, Eli Muchtar, et al.
Blood Cancer Journal|December 10, 2023
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myelomaCharalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.
Pageof 48

Showing results (321-330 of 471) with videos related to

Sort By:
Pageof 48
Annals of Medicine|March 9, 2017
Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognitionEli Muchtar, Angela Dispenzieri, Martha Q Lacy, et al.
Mayo Clinic Proceedings|October 8, 2016
Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and OutcomeEli Muchtar, Daniele Derudas, Michelle Mauermann, et al.
European Journal of Haematology|January 29, 2008
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndromeAngela Dispenzieri, Martha Q Lacy, Suzanne R Hayman, et al.
Bone Marrow Transplantation|May 3, 2020
Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplantAbdullah S Al Saleh, M Hasib Sidiqi, JaeWon Lee, et al.
British Journal of Haematology|July 13, 2017
Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantationEli Muchtar, Angela Dispenzieri, Martha Q Lacy, et al.
American Journal of Hematology|November 25, 2021
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patientsPatrick W Mellors, Taxiarchis Kourelis, Ronald S Go, et al.
American Journal of Hematology|July 8, 2023
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myelomaSaurabh Zanwar, Matthew Ho, Yi Lin, et al.
Blood Cancer Journal|October 3, 2020
Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myelomaMarcella A Tschautscher, Dragan Jevremovic, Francis K Buadi, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|December 19, 2022
The impact of Post-Transplant doxycycline in AL amyloidosis - updated results after Long-Term follow upNadine Abdallah, Angela Dispenzieri, Eli Muchtar, et al.
Blood Cancer Journal|December 10, 2023
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myelomaCharalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.
Pageof 48